Cite
HARVARD Citation
Sprigg, N. et al. (2018). Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial. Lancet. 391 (10135), pp. 2107-2115. [Online].